Literature DB >> 15711738

Asymptomatic postoperative deep vein thrombosis and the development of postthrombotic syndrome. A systematic review and meta-analysis.

Peer Wille-Jørgensen1, Lars N Jorgensen, Michael Crawford.   

Abstract

Perioperative antithrombotic clinical regimens have reduced the incidence of postoperative deep venous thrombosis (DVT). Long-term effects of asymptomatic postoperative DVT have been studied in a number of clinical trials and the present review describes the clinical significance of asymptomatic postoperative DVT regarding the possible development of postthrombotic syndrome (PTS). We performed a systematic review of reference databases focusing upon studies including patients suspected of having postoperative DVT and reporting subsequent cases of PTS at the end of a well-defined follow-up period. The included studies were stratified according to type of screening method and applied statistics. Over-all evaluation included meta-analyses based upon the Cochrane software package. The overall relative risk of developing PTS was 1.58 (95% confidence intervals: 1.24-2.02) in patients suffering from asymptomatic DVT as compared to patients without DVT (p<0.0005). In conclusion, asymptomatic postoperative DVT is associated with an increased risk of late development of PTS. The finding emphasizes that postoperative DVT, diagnosed by means of well-defined objective measures, remains the correct scientific endpoint in trials evaluating the efficacy of preoperative antithrombotic treatment regimens.

Entities:  

Mesh:

Year:  2005        PMID: 15711738     DOI: 10.1160/TH04-09-0570

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  24 in total

1.  Value-of-information analysis to reduce decision uncertainty associated with the choice of thromboprophylaxis after total hip replacement in the Irish healthcare setting.

Authors:  Laura McCullagh; Cathal Walsh; Michael Barry
Journal:  Pharmacoeconomics       Date:  2012-10-01       Impact factor: 4.981

Review 2.  The post-thrombotic syndrome: the forgotten morbidity of deep venous thrombosis.

Authors:  Susan R Kahn
Journal:  J Thromb Thrombolysis       Date:  2006-02       Impact factor: 2.300

Review 3.  The postthrombotic syndrome.

Authors:  Raffaele Pesavento; Sabina Villalta; Paolo Prandoni
Journal:  Intern Emerg Med       Date:  2009-12-10       Impact factor: 3.397

4.  Higher soluble P-selectin is associated with chronic venous insufficiency: the San Diego Population Study.

Authors:  Locke J Bryan; Peter W Callas; Michael H Criqui; Mary Cushman
Journal:  Thromb Res       Date:  2012-08-12       Impact factor: 3.944

5.  Risk factors for peripheral venous disease resemble those for venous thrombosis: the San Diego Population Study.

Authors:  M Cushman; P W Callas; J O Denenberg; E G Bovill; M H Criqui
Journal:  J Thromb Haemost       Date:  2010-05-21       Impact factor: 5.824

6.  A follow-up study of the fate of small asymptomatic deep venous thromboses.

Authors:  Stefan Rosfors; Lena M Persson; Gerd Lärfars; Lasse J Lapidus
Journal:  Thromb J       Date:  2010-02-12

Review 7.  Incidence and cost burden of post-thrombotic syndrome.

Authors:  Aneel A Ashrani; John A Heit
Journal:  J Thromb Thrombolysis       Date:  2009-02-18       Impact factor: 2.300

Review 8.  Treatment of Isolated Below the Knee Deep Vein Thrombosis.

Authors:  Gualtiero Palareti; Michelangelo Sartori
Journal:  Curr Atheroscler Rep       Date:  2016-07       Impact factor: 5.113

Review 9.  New oral antithrombotics: focus on dabigatran, an oral, reversible direct thrombin inhibitor for the prevention and treatment of venous and arterial thromboembolic disorders.

Authors:  Ola E Dahl
Journal:  Vasc Health Risk Manag       Date:  2012-01-25

10.  Oral thromboprophylaxis following total hip or knee replacement: review and multicentre experience with dabigatran etexilate.

Authors:  D Kendoff; C Perka; H M Fritsche; T Gehrke; R Hube
Journal:  Open Orthop J       Date:  2011-12-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.